Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 28, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - May 28, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 100     Next >>     Go To Page:

5/19/17 - AAP Responds to FDA Reauthorization Act of 2017 as Passed by House Subcommittee
The American Academy of Pediatrics issued the following news release:. The FDA Reauthorization Act of 2017 passed today by the U.S. House of Representatives Energy and Commerce Health Subcommittee to reauthorize U.S. Food and Drug Administration user fees is a missed opportunity for children. The House vote comes one week after the U.S. Senate Comm
5/19/17 - Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer (NSCLC)
Novartis International AG/ Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer. *Phase III trial, first-line treatment with Zykadia resulted in improved progression-free survival over SOC chemotherapy with maintenance, including in patients with brain metastases* Zykadia is...
5/19/17 - Patent Issued for Method for Treatment of Acne Using Pharmaceutical Compositions of Clindamycin and Adapalene (USPTO 9636353)
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Mittal, Ravindra; Roy, Sunilendu Bhushan; Kothari, Jay Shantilal; Sheikh, Shafiq; Patel, Jitendra Dasharathlal; Pancholi, Jinesh Suresh, filed on October 19, 2011, was published online on May 2, 2017. The patent's
5/19/17 - Prescription Antiacne Drugs Market - Trends and Opportunities for the Industry by 2023
Albany, NY 05/19/2017 Prescription Antiacne Drugs Market. Acne is a common disorder that leads to formation of lesions or zits. The disease is characterized by overproduction of sebum due to high level of production of male hormone named as androgen during puberty.
5/18/17 - Avion Pharmaceuticals, LLC, Responds to First Data Bank Decision: 'Pregnant Women And Expectant Infants Will Be Compromised'
Avion Pharmaceuticals, LLC, the makers of the Prenate line of prescription prenatal vitamins, has been informed of an announcement from First Data Bank, Inc. First Data Bank is the publisher of pharmaceutical information that is used within healthcare information systems for medication decision support and negotiating reimbursement rates paid
5/18/17 - Innovus Pharma Files Its Product License Application in Canada for the Commercialization of Vesele as a Natural Health Product to Help Improve Symptoms of Sexual Dysfunction
Innovus Pharmaceuticals, Inc. today announced that the Company filed its Product License Application with Health Canada as a Natural Health Product to market its current best-selling product Vesele with the indication to Help Improve Symptoms of Sexual Dysfunction. If accepted by Health Canada, Vesele will be available over-the-counter
5/18/17 - Over-the-Counter Drug 2017 Global Market Expected to Grow at CAGR 6.19% and Forecast to 2020
OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. Get a Sample Report@ https://www.wiseguyreports.com/sample-request/605454-global-over-the-counter-drug-market-2016-2020. The market is divided into the following segments based on...
5/17/17 - AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology (ASCO) Annual Meeting
AbbVie, a global biopharmaceutical company, today announced it will present data about the company's portfolio of approved and investigational oncology medicines during the 53 rd Annual Meeting of the American Society of Clinical Oncology, June 2-6, in Chicago. "AbbVie's data presentations at this year's ASCO meeting reinforce our diverse and...
5/17/17 - Credence Research: Chronic Idiopathic Constipation (CIC) Drugs Market Size, Share, Growth, Strategies, Outlook and Forecast 2017 2025
According to a recently published report by Brisk Insights, the Global Chronic Idiopathic Constipation Drug Market is expected to grow at the CAGR of 6.4% during 2017-2025. The global chronic idiopathic constipation drug market is segmented on the basis of drug, prescription and geography. It is estimated that more than 15% of adult population in U
5/17/17 - Credence Research: Opioid Induced Constipation Drugs Market Size, Share, Growth, Strategies and Forecast 2017 2025
According to a recently published report by Brisk Insights, the Global Opioid Induced Constipation Drugs Market is expected to grow at the CAGR of 4.6% during 2017-2025. The global opioid induced constipation drugs market is segmented on the basis of drug type, prescription type and geography. The report on global opioid induced constipation drugs
5/17/17 - VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, announces today it has entered into a Canada- wide distribution agreement for INSTI HIV-1/HIV-2 Antibody Test. "We are very pleased to have acquired the Canadian distribution rights to INSTI," commented Bob Rai, CEO.
5/17/17 - VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, announces today it has entered into a Canada- wide distribution agreement for INSTI (R) HIV-1/HIV-2 Antibody Test. "We are very pleased to have acquired the Canadian distribution rights to INSTI," commented Bob Rai, CEO.
5/16/17 - Active Pharmaceutical Ingredients Market to Reach US $219.60 Billion by 2023; Global Industry Volume by Region 2015 - 2023
Transparency Market Research Report Added "Active Pharmaceutical Ingredients Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015- 2023" Albany, NY 05/16/2017 Active pharmaceutical ingredients are bulk drug products that are used as raw materials for formulations. APIs of good quality are essential for the manufactu
5/16/17 - How to lower your Medicare costs
Driving near Monterey, Calif., recently, I stopped at a roadside stand to buy some freshly-picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug cove
5/16/17 - Innovus Pharma Signs Exclusive License and Distribution Agreement with Densmore for Zestra in France and Belgium for Female Sexual Arousal Disorder
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, announced today the si
5/16/17 - KONARED CORP - 10-Q - MANAGEMENTS' DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
Certain information included herein contains forward-looking statements that involve risks and uncertainties within the meaning of Sections 27 A of the Securities Act, as amended; Section 21 E of the Securities Exchange Act of 1934. The factors that might cause such differences include, among others, the following: we have incurred significant loss
5/16/17 - Sunovion Data Presentations at Annual American Psychiatric Association Meeting Showcase Growing Psychiatry Franchise
Sunovion Pharmaceuticals Inc. will present four research posters on Latuda and one on novel drug candidate dasotraline at the 170 th Annual Meeting of the American Psychiatric Association, which will be held May 20-24, 2017, in San Diego, California. LATUDA is an atypical antipsychotic agent approved in the U.S. for the treatment of major depres
5/15/17 - BRIEF: Durham's Patheon acquired; deal valued at $7.2 billion [The News & Observer (Raleigh, N.C.)]
May 15 Patheon, a Durham pharmaceutical services company, is being bought by Thermo Fisher Scientific at a deal valued at $7.2 billion, or $35 a share. The company employs about 9,000 people worldwide, including about 150 in Durham. The deal gives Massachusetts- based Thermo Fisher a foothold in the high-growth pharmaceutical services market, whi
5/15/17 - Credence Research: Global In-Vitro Diagnostics Market Size, Share, Growth, Outlook, Opportunities and Forecast 2016 2022 : Credence Research
According to the latest report published by Credence Research, Inc. "Global In-vitro Diagnostics Market- Growth, Opportunities, Competitive Analysis, and Forecast, 2016- 2022," the in-vitro diagnostics market was valued at USD 60,468.7 Mn in 2015, and is expected to reach USD 81,345.1 Mn by 2022, expanding at a CAGR of 4.2% from 2016 to 2022..
5/15/17 - Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced first quarter 2017 financial results with Net Revenues of $9.6 million and Adjusted Earnings of $0.3 million or $0.02 per share. "We are off to a fast start in 2017," said A.J. Kazimi, Chief Executive Officer o
5/15/17 - How These Generic Drugs Stocks are Faring? Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy
Pre-market today, Stock-Callers.com directs attention to Akorn Inc., Collegium Pharmaceutical Inc., Momenta Pharmaceuticals Inc., and Diplomat Pharmacy Inc.. Lake Forest, Illinois headquartered Akorn Inc.' s shares recorded a trading volume of 2.13 million shares last Friday. The stock finished the trading session 0.06% lower at $33.15.
5/15/17 - Innovus Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Friday, May 12, 2017
By a News Reporter-Staff News Editor at Pharma Business Week Innovus Pharmaceuticals, Inc.,, announced that the Company will release its first quarter 2017 financial results and provide a corporate update on Friday, May 12, 2017, after the close of the U.S. financial markets. About Innovus Pharmaceuticals, Inc. Headquartered in San Diego, Innovus
5/15/17 - INTRICON CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Headquartered in Arden Hills, Minnesota, IntriCon Corporation is an international company engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. In addition to its operations in Minnesota, the Company has facilities in Illinois, Singapore, Indonesia,. the United Kingdom and Germany.
5/15/17 - NEXPOINT CAPITAL, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.
The information contained in this section should be read in conjunction with our unaudited financial statements and related notes thereto included elsewhere in this quarterly report on Form 10- Q. In this report, "we," "us" and "our" refer to NexPoint Capital, Inc. Forward-Looking Statements Some of the statements in this quarterly report on Form 1
5/15/17 - SKINVISIBLE INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995,
Articles(s): 1 - 25 of 100     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415